The Future of Multiple Sclerosis Care

Conventional MS care, which follows a stepwise treatment escalation path, has recently been challenged. The new approach promotes early and aggressive use of potent medications beginning immediately upon diagnosis. What Real-World consequences does this change in treatment bring? How might this innovative strategy revolutionize the lives of those affected by this challenging neurological condition?

Our experts Prof. Dr. med. Tjalf Ziemssen, Head of the Center for Clinical Neurosciences, Professor of Clin. Neurosciences, Dresden University Hospital and PD Dr. med. Benjamin Friedrich, Co-Founder & CMO, Temedica discussed these questions in a 30-minutes webinar.

Get your recording to stay up-to-date!

The webinar is held in German.